tiprankstipranks
ADC Therapeutics: Updated data from Phase 2 Zynlonta study published in Lancet
PremiumThe FlyADC Therapeutics: Updated data from Phase 2 Zynlonta study published in Lancet
1M ago
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
Premium
The Fly
Molson Coors upgraded, Rivian downgraded: Wall Street’s top analyst calls
2M ago
ADC Therapeutics Highlights Q3 Advances and Strategic Focus
Premium
Company Announcements
ADC Therapeutics Highlights Q3 Advances and Strategic Focus
2M ago
ADC Therapeutics files $300M mixed securities shelf
PremiumThe FlyADC Therapeutics files $300M mixed securities shelf
5M ago
ADC Therapeutics sees cash runway into mid-2026
Premium
The Fly
ADC Therapeutics sees cash runway into mid-2026
6M ago
ADC Therapeutics reports Q2 adjusted EPS (25c), consensus (46c)
Premium
The Fly
ADC Therapeutics reports Q2 adjusted EPS (25c), consensus (46c)
6M ago
ADC Therapeutics participates in a conference call with JPMorgan
PremiumThe FlyADC Therapeutics participates in a conference call with JPMorgan
7M ago
ADC Therapeutics rises 15.4%
Premium
The Fly
ADC Therapeutics rises 15.4%
8M ago
Wynn Resorts upgraded, PayPal initiated: Wall Street’s top analyst calls
Premium
The Fly
Wynn Resorts upgraded, PayPal initiated: Wall Street’s top analyst calls
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100